Is hospital admission a sufficiently sensitive outcome measure for evaluating medication review services? A descriptive analysis of admissions within a randomised controlled trial

International Journal of Pharmacy Practice

Volumn 15, Issue 2, 2007, Pages 85-91

  Krska, Janet ^a   Hansford, Denise ^b   Seymour, D Gwyn ^c   Farquharson, Judy ^d  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d Albyn Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZAPROPAZONE; CAPTOPRIL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DICLOFENAC; DIHYDROCODEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GAVISCON; GLIPIZIDE; GLYCERYL TRINITRATE; NITRAZEPAM; RANITIDINE; TIAPROFENIC ACID; WARFARIN;

AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG WITHDRAWAL; DUODENUM ULCER; DYSPEPSIA; EMERGENCY PATIENT; EPISTAXIS; GENERAL PRACTITIONER; HEALTH SERVICE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STOMACH ULCER; TONGUE DISEASE; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT;

EID: 34249818168     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.15.2.0002     Document Type: Article

References (23)

1. Krska J, Cromarty JA, Arris F et al. Pharmacist-led medication review in patients over 65: randomized, controlled trial in primary care. Age Ageing 2001;30:205-11.
2. Zermansky AG, Petty DR, Raynor DK et al. Clinical medication review by a pharmacist of elderly patients on repeat prescriptions in general practice: a randomised controlled trial. BMJ 2001;323:1340-3.
3. Nazareth I, Burton A, Shulman S, Haines A, Timberall H. A pharmacy discharge plan for hospitalised elderly patients - a randomized controlled trial. Age Ageing 2001;30:33-40.
4. Holland R, Lenaghan, Harvey I et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005;330:293-7.
5. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.
6. Cunningham G, Dodd TRP, Grant DJ, McMurdo MET, Richards RME. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997;26:375-82.
7. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health-Syst Pharm 2003;60:1123-9.
8. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998;46:174-80.
9. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med 1998;158:1067-72.
10. Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized control trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007; Jan 31 [Epub ahead of print].
11. Bernsten C, Bjorkman I, Caramona M et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. A multi-centre study in seven European countries. Drugs Aging 2001;18:63-77.
12. Sellors J, Kaczorowski J, Sellors C et al. A randomised controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003;169:17-22.
13. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheik A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006;15:23-31.
14. Krska J, Hansford D, Jamieson D, Arris F, Cromarty JA, Abbott S, McGuire A. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91-100.
15. Hallas J, Harvald B, Gram LF et al. Drug-related hospital admissions: the role of definitions and intensity of data collection and the possibility of prevention. J Intern Med 1990;228:83-90.
16. Howard RL, Avery AA, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5.
17. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharm J 2003;270:583-6.
18. Morris, CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity - determining valid indicators. Int J Qual Health Care 2002;14:183-98.
19. Morris, CJ. Cantrill, JA. Preventing drug-related morbidity - the development of quality indicators. J Clin Pharm Ther 2003;28:295-305.
20. Pharmaceutical Services Negotiating Committee. 2005 The new contract for community pharmacy - Advanced services - Medicines Use Review - Service specification. Available from www.psnc.org.uk (accessed December 12, 2006).
21. Fish A, Watson MC, Bond CM. Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract. 2002;10:225-34.
22. Hawksworth G, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695-700.
23. Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care service: a systematic review of published studies 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract 2005;13:53-70.